Conflicts of Interest in Bronchoscopy Research: Is Self-Reporting Sufficient?
- PMID: 39426717
- PMCID: PMC12001812
- DOI: 10.1016/j.chest.2024.10.006
Conflicts of Interest in Bronchoscopy Research: Is Self-Reporting Sufficient?
Abstract
Background: Robotic assisted bronchoscopy has been enthusiastically adopted in the United States and has transformed the treatment of patients with indeterminate pulmonary nodules. Unprecedented industry investments in research, development, and marketing have profoundly affected the bronchoscopy landscape, leading to concerns that conflicts of interest could influence the validity of bronchoscopy studies. Disclosures of conflicts of interest in research are predicated on open and transparent self-reporting.
Research question: Are self-reported relevant conflicts of interest in articles pertaining to robotic assisted bronchoscopy accurate when compared with publicly available payments on the Open Payments Database of the Centers for Medicare & Medicaid Services?
Study design and methods: All articles pertaining to robotic assisted bronchoscopy indexed on PubMed between 2016 and 2022 were screened for relevance. Articles appearing in the 5 journals with the most relevant publications were selected. General, research, and associated research payments reported in the Open Payments Database were recorded for each US physician-author with available data. "Relevant payments" refers to transactions made to authors by bronchoscopy-related companies. Documentation of all payments involving these companies during the 3 years before the submission date of an article was obtained. These payments were compared with the self-reported conflicts of interest for each author, per article, and the number and value of payments were categorized and totaled.
Results: Twenty-seven articles were included, accounting for 75 US physicians with data reported in the Open Payments Database. Of the $17 million in relevant payments reported, $9.9 million were not disclosed (57%). Sixty-eight of 75 authors (91%) had incomplete physician disclosures. Excluding food and beverage payments, 60 authors had incomplete disclosures (80%).
Interpretation: Relevant conflicts of interest appear to be inconsistently disclosed in publications on robotic assisted bronchoscopy, suggesting that self-reporting may be an insufficient strategy. A centralized disclosure process that is automated or easier to use should be considered.
Keywords: Open Payments Database; bronchoscopy; conflict of interest; disclosures; robotic assisted bronchoscopy; robotic bronchoscopy.
Copyright © 2024 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: A. R. received food and beverage payments from Steris Corporation. R. P. received consulting payments from Noah Medical. S. S. received education payments from Intuitive Surgical; food and beverage payments from Ethicon, Intuitive Surgical, Pulmonx Corporation, and Steris Corporation; and travel and lodging payments from Ethicon and Intuitive Surgical. R. J. L. received education payments from Intuitive Surgical; food and beverage payments from ERBE USA, Intuitive Surgical, Medtronic, Pulmonx Corporation, and Steris Corporation; and travel and lodging payments from Intuitive Surgical. F. M. received compensation for services other than consulting from Intuitive Surgical and Medtronic; consulting payments from Intuitive Surgical, Johnson & Johnson, and Medtronic; education payments from Intuitive Surgical; food and beverage payments from ERBE USA, Intuitive Surgical, Medtronic, Pulmonx Corporation, and Steris Corporation; and travel and lodging payments from Intuitive Surgical. F. M. also received research support from Erbe Elektromedizin GmbH, Medtronic, and Steris Corporation. None declared (K. M. L., T. A. K., J. W., G. D., J. D. D., E. J. G.).
References
-
- US Food and Drug Administration Center for Devices and Radiological Health. 510(k) Premarket Notification. Updated February 19, 2024. US Food and Drug Administration website. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K173760
-
- US Food and Drug Administration Center for Devices and Radiological Health. Premarket Notification 510(k). Updated December 5, 2023. US Food and Drug Administration website. https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-...
-
- Ravi V.K., Ross J.S. Modernizing the FDA’s 510(k) pathway. N Engl J Med. 2019;381(20):1891–1893. - PubMed
-
- Landeen K.C., Langerman A., Maldonado F. An oversight in oversight: reconciling the medical device industry, clinicians, and regulation. Chest. 2022;161(1):300–302. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
